Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform
November 10, 2023 05:52 ET
|
Smart Immune
Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform Clinical-stage T-cell progenitor therapy aims to re-arm the immune system against cancer and infection New class of...
THOR EQUITIES GROUP COMPLETES REHABILITATION AND TRANSFORMATION OF 6 RUE DE SÈVRES IN PARIS
July 06, 2023 17:18 ET
|
Thor Equities Group
PARIS, France, July 06, 2023 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in urban real estate development, leasing and management, announced it has completed the rehabilitation and...
RODEO FX EXTENDS ITS GLOBAL REACH WITH A BRAND-NEW STUDIO IN PARIS
June 23, 2023 13:50 ET
|
Rodeo FX
Paris, 11e Arrondissement, France, June 23, 2023 (GLOBE NEWSWIRE) -- Rodeo FX, an international visual effects studio and renowned partner of the most prominent film and television studios in the...
New.to: Travel Site Launches With The Aim To Be A One-Stop Shop For Everything To Do In A Visitors Chosen Location
May 25, 2023 09:00 ET
|
New.to
Paris, France, May 25, 2023 (GLOBE NEWSWIRE) -- New.to – Expert Travel Guides is excited to announce the launch of its new website that aims to be a one-stop shop for everything to do in a visitor’s...
Orphalan announces US commercial launch of Cuvrior™ for the treatment of Wilson disease
April 20, 2023 07:00 ET
|
Orphalan
Cuvrior™ now available in the US for the treatment of adult patients with stable Wilson disease who are de-coppered and tolerant to penicillamine — Oral administration offers dosing flexibility and...
CryptoCurrencyWire Designated Official Newswire for Paris Blockchain Week
March 17, 2023 15:21 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, March 17, 2023 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire -- IBN (“InvestorBrandNetwork”), a multifaceted communications organization with 50+ brands, is pleased to announce...
Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating central nervous system disorders
March 07, 2023 04:00 ET
|
Jeito Capital
Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating central...
Jeito Capital co-dirige un financement de 104 millions d’euros pour Noema Pharma, une biopharma pour Noema Pharma, une biopharma ciblant les maladies graves du système nerveux central
March 07, 2023 04:00 ET
|
Jeito Capital
Jeito Capital co-dirige un financement de 104 millions d’euros pour Noema Pharma, une biopharma ciblant les maladies graves du système...
Paris, France Receives the 2023 Sustainable Transport Award for Progress on Accessibility, Sustainability, and Inclusion
February 06, 2023 10:45 ET
|
ITDP
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The Institute for Transportation and Development Policy (ITDP) and the Sustainable Transport Award Committee are proud to announce Paris, France as the...
Jeito Capital renforce son soutien à Pulmocide en participant à un nouveau financement de 52 millions de dollars
December 06, 2022 07:00 ET
|
Jeito Capital
Jeito Capital renforce son soutien à Pulmocide en participant à un nouveau financement de 52 millions de dollars Ce nouveau tour de table permettra d’accélérer le développement clinique et...